ConductScience.org, home

Trial · NCT03568175

A Study of JR-141 in Patients With Mucopolysaccharidosis II

NCT03568175, Phase 2, Phase 3, Completed, JCR Pharmaceuticals Co., Ltd.

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. A Study of JR-141 in Patients With Mucopolysaccharidosis II. Trials, record NCT03568175. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03568175

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
A Study of JR-141 in Patients With Mucopolysaccharidosis II
NCT number
NCT03568175
Status
Completed
Phases
Phase 2, Phase 3
Enrollment
28 participants, actual
Lead sponsor
JCR Pharmaceuticals Co., Ltd.
Conditions
Mucopolysaccharidosis II
Interventions
JR-141
First posted
2018-06-26
Last updated
2022-11-14

Source ClinicalTrials.gov

Registered outcomes15

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange From Baseline in Heparan Sulfate Levels in Cerebrospinal FluidBaseline to 52 weeks
SecondaryChange From Baseline in Serum Heparan Sulfate Levels.Baseline, 24-26 weeks, 50-52 weeks
SecondaryChange From Baseline in Serum Dermatan Sulfate Levels.Baseline, 24-26 weeks, 50-52 weeks
SecondaryChange From Baseline in Urinary Heparan Sulfate Levels.Baseline, 25 weeks, 52 weeks
SecondaryChange From Baseline in Urinary Dermatan Sulfate Levels.Baseline, 25 weeks, 52 weeks
SecondaryChange From Baseline in Liver Volumes.Baseline, 25 weeks, 52 weeks
SecondaryChange From Baseline in Spleen Volumes.Baseline, 25 weeks, 52 weeks
SecondaryChange From Baseline in Cardiac Function.Baseline, 25 weeks, 52 weeks
SecondaryChange From Baseline in 6-minute Walk Test Distance.Baseline, 25 weeks, 52 weeksItem 9 will be administrated only in patients judged by the investigator or subinvestigator to be possible to perform the 6-minutes walk test
SecondaryChange From Baseline in Joint Range of Motion.Baseline, 25 weeks, 52 weeks

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03568175

GET https://conductscience.org/api/trials/v1/NCT03568175/registered